Unknown PHASE2 INTERVENTIONAL 2-arm NCT02857530

Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia

Sponsor: Tianjin Medical University General Hospital

Updated 6 times since 2017 Last updated: Aug 4, 2016 Started: Aug 31, 2016 Primary completion: Jul 31, 2019 Completion: Jul 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Anemia, Aplastic and is currently ongoing. Tianjin Medical University General Hospital leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Aug 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Aug 2020 [monthly]

Not Yet Recruiting PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tianjin Medical University General Hospital

Data source: Tianjin Medical University General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tianjin, China